mianserin has been researched along with Dyslipidemia in 2 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, HR | 1 |
| Woo, YS | 1 |
| Wang, HR | 1 |
| Shim, IH | 1 |
| Jun, TY | 1 |
| Bahk, WM | 1 |
| Moffatt, A | 1 |
| Ticehurst, S | 1 |
2 other studies available for mianserin and Dyslipidemia
| Article | Year |
|---|---|
Does mirtazapine interfere with naturalistic diabetes treatment?
Topics: Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol; | 2014 |
Mirtazapine-induced massive dyslipidaemia in an elderly woman.
Topics: Aged; Antidepressive Agents, Tricyclic; Dyslipidemias; Female; Humans; Mianserin; Mirtazapine | 2013 |